Hydrogel delivery of sting immunotherapy for treatment cancer

dc.contributor.assigneeRice Universityen_US
dc.contributor.assigneeThe Board of Regents of the University of Texas Systemen_US
dc.contributor.publisherUnited States Patent and Trademark Officeen_US
dc.creatorYoung, Simonen_US
dc.creatorLeach, Daviden_US
dc.creatorHartgerink, Jeffrey D.en_US
dc.date.accessioned2024-05-02T16:55:22Zen_US
dc.date.available2024-05-02T16:55:22Zen_US
dc.date.filed2018-06-15en_US
dc.date.issued2024-04-30en_US
dc.description.abstractIn one aspect, the present disclosure provides for novel compositions of matter comprising multi domain peptide (MDP) hydrogels and cyclic dinucleotides (CDNs). Also disclosed are method of using such compositions in the treatment of cancer, including in particular the treatment of head and neck cancers, such as those resistant to CDN therapy.en_US
dc.digitization.specificationsThis patent information was downloaded from the US Patent and Trademark website (http://www.uspto.gov/) as image-PDFs. The PDFs were OCRed for access purposes.en_US
dc.format.extent51en_US
dc.identifier.patentIDUS11969499B2en_US
dc.identifier.urihttps://hdl.handle.net/1911/115490en_US
dc.language.isoengen_US
dc.titleHydrogel delivery of sting immunotherapy for treatment canceren_US
dc.typeUtility patenten_US
dc.type.dcmiTexten_US
dc.type.genrepatentsen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
US11969499B2.pdf
Size:
1.91 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.7 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections